Overview
Novisc Pharma is a company that specializes in medical devices, particularly in the development of hyaluronic acid products for orthopedic treatments. They offer Hya-Joint 1%, a long-lasting hyaluronic acid solution, and Hya-Joint Plus 2%, a highly concentrated formulation designed for single-injection therapy. Their products aim to improve joint lubrication, flexibility, and mobility, and are supported by necessary quality certifications.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2013-02-06. Active
34 1050 1025 1000 0091 3214 5666
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
4 public aid cases recorded, with a total value of $68,083.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 18, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282 | Prezydent Miasta Stołecznego Warszawy | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,989 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $193 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Konrad Antoni Szostek (39) | 380 | $10,804.97 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Konrad Antoni Szostek (39)  | Shareholder of a limited liability company, 38000.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Citipharmsp. z o.o. + limited partnership | $1,829,937.74 | citipharm.pl | |
| Vente Amicalesp. z o.o. | $1,850,028.63 | venteamicale.pl | |
| Passimedsp. z o.o. | $1,677,642.39 | passimed.pl | |
| Novicaresp. z o.o. | $1,512,398.66 | novicare.pl | |
| BL Medicasp. z o.o. + limited partnership | $886,794.58 | blmedica.pl | |
| Lock Pharmasp. z o.o. | $737,058.47 | lockpharma.pl | |
| Orthoactivesp. z o.o. | $617,449.08 | orthoactive.pl | |
| Support-Pharmasp. z o.o. | $521,132.71 | support-pharma.pl | |
| Biocomsp. z o.o. | $433,929.05 | biocom.net.pl | |
| Beauty Care Solutionsp. z o.o. | $391,209.94 | ohhira.pl |
Change history
| Date | Event |
|---|---|
| 2015-07-20 | PKD change (Removed: 47.73, 47.74, 47.75, 47.91, 47.99, 63.11.Z, 70.22.Z, 73.2, 82.20.Z, 82.99.Z; Added: 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 47.99.Z, 73.20.Z) |
| 2012-12-13 | Entered in the register |
FAQ
Last updated: 2026-09-19